Association Between Metabolic Dysfunction-Associated Fatty Liver Disease and Cardiovascular Risk in Patients With Rheumatoid Arthritis: A Cross-Sectional Study of Chinese Cohort

Association Between Metabolic Dysfunction-Associated Fatty Liver Disease and Cardiovascular Risk in Patients With Rheumatoid Arthritis: A Cross-Sectional Study of Chinese Cohort

BackgroundThe nomenclature from non-alcoholic fatty liver disease (NAFLD) to metabolic dysfunction-associated fatty liver disease (MAFLD) is considered to identify more cardiovascular disease (CVD) risks in the general population. Patients with rheumatoid arthritis (RA) carry an excess risk for CVD....

Full description

Bibliographic Details
Main Authors: Yao-Wei Zou, Qian-Hua Li, Jing-Wei Gao, Jie Pan, Jian-Da Ma, Le-Feng Chen, Jian-Zi Lin, Ying-Qian Mo, Xue-Pei Zhang, Pin-Ming Liu, Lie Dai
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-05-01
Series:Frontiers in Cardiovascular Medicine
Subjects:
cardiovascular disease
rheumatoid arthritis
metabolic dysfunction-associated fatty liver disease
non-alcoholic fatty liver disease
inflammation
Online Access:https://www.frontiersin.org/articles/10.3389/fcvm.2022.884636/full

Internet

https://www.frontiersin.org/articles/10.3389/fcvm.2022.884636/full

Similar Items